Xenon Pharmaceuticals USA, Inc.

Barbara Filice signed Xenon Pharmaceuticals USA, Inc.'s 2024 Form 5500 as plan administrator.

• Barbara Filice — Plan Administrator — Form 5500 signer

Signer names are public record from the Form 5500 e-signature.

Xenon Pharmaceuticals USA, Inc.'s EIN is 81-4576210.

Download the official 2024 Form 5500 (PDF) for Xenon Pharmaceuticals USA, Inc. from the U.S. Department of Labor's EFAST2 system.

Xenon Pharmaceuticals USA, Inc.'s plan includes profit-sharing, a 401(k) feature, a self-directed brokerage window, ERISA 404(c) participant direction, a default investment (QDIA).